N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin
N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin Brand names, N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin Analogs
N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin Brand Names Mixture
- No information avaliable
N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin Chemical_Formula
C52H74N16O15S2
N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin RX_link
No information avaliable
N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin fda sheet
N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin msds (material safety sheet)
N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin Synthesis Reference
No information avaliable
N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin Molecular Weight
1227.37 g/mol
N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin Melting Point
No information avaliable
N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin H2O Solubility
No information avaliable
N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin State
No information avaliable
N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin LogP
-6.239
N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin Dosage Forms
No information avaliable
N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin Indication
Oesophageal varices with bleeding
N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin Pharmacology
No information avaliable
N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin Absorption
No information avaliable
N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin side effects and Toxicity
No information avaliable
N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin Patient Information
No information avaliable
N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin Organisms Affected
Humans and other mammals
